895P Cost effectiveness of stereotactic ablative radiotherapy (SABR) alone in comparison with systemic treatment and SABR in oligometastatic head and neck cancer in the GORTEC 2014-04 OMET randomized phase II study
Autor: | Thariat, J., Falcoz, A., Nadin, L., Bourhis, J., Sun, X., Nerich, V. |
---|---|
Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S634-S634 |
Databáze: | ScienceDirect |
Externí odkaz: |